Working with a doctor or nutritionist, older adults can develop a plan for weight management that addresses their individual needs. Weight management can be a complex process for people ages 65 years ...

Omada Health (OMDA) released results from a real-world analysis that showed 63% of Omada members maintained or continued to lose weight 12 months after discontinuing GLP-1s,1 challenging widespread ...

While GLP-1 usage grows, there's still a dearth of treatment options for patients with an overweight or obesity diagnosis.

Weight management becomes more complex as people age due to health considerations, mobility challenges, and nutritional factors. Understanding the role of diet and exercise in weight management can ...

Becca, a former member of the group After School, shot at the K-pop appearance management system. On the 23rd, Becca published an article titled 「K-pop and weight」. "Honestly, during my time in K-pop, ...

There’s no one-size-fits-all approach. Whether you’re looking to lose, gain, or maintain weight, trust Healthline’s Weight Management newsletter to guide you. Start making progress toward your goals ...

Social media influencers claim ‘Ozempatches’ and the like can help you lose weight. Here’s what experts have to say. GLP-1 patches trending on social media promise Ozempic-like weight loss results.

A massive international study has shown that the experimental oral obesity drug orforglipron can help patients shed over 10% of their body weight, with nearly one in five losing 20% or more. Unlike ...

Eli Lilly's shares have increased by about 10% over the past month. Clinical progress in the past few weeks has helped solidify its lead in the weight loss market. The company's prospects remain ...

Physical, emotional, and lifestyle changes may make weight loss harder after 40, but diet, exercise, and self-care practices can help. Hormonal and metabolic changes, stress, poor sleep, and the ...

Much excitement has built in recent years on the new class of incretin drugs that include glucagon-like-peptide-1 inhibitors (single agonists such as semaglutide) and also dual glucose-dependent ...